AEIN GER Week ended 07 Aug 2026

Weekly Investor Report

Allgeier SE · Technology · Information Technology Services

Open interactive chart View report data
Latest close 16.75 EUR
0.9% latest week
Weekly setup

Mixed setup

The weekly trend is not active. Price is -1.2% below the Trend Line and sits at 31.0% of its 52-week range. The latest completed week returned 0.9%, after a 3.7% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks strongly; valuation is inexpensive relative to peers. The latest news-sentiment score is 50/100.

Setup score 38 out of 100
Latest Close 16.75 EUR 7 Aug 2026
1W Return 0.9% latest completed week
4W Return 3.7% short-term follow-through
12W Return 16.8% quarterly tape
Trend Breadth 15.4% 8 of 52 weeks active
Volume Ratio 1.0x vs 13-week average
What is working
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Activity pressure is weak, so confirmation is not yet broad enough.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 0.9% Latest completed week; four-week move 3.7%. Indicator stack 8/81 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Recent Activity-pressure buy-signal status for institutional accumulation timing. News sentiment 50/100 4 relevant articles in the latest sentiment read.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -1.2% below the Trend Line and sits at 31.0% of its 52-week range. The latest completed week returned 0.9%, after a 3.7% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.0x the 13-week average. Participation is around or above normal and provides reasonable confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul 7 Aug
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.1612-week average 0.09

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure3/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.16Current proprietary activity-pressure read.
Buy signals1Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 3.7% over four weeks, 16.8% over 12 weeks, and -9.2% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W0.9%
4W3.7%
12W16.8%
26W-15.0%
52W-9.2%
Active trend streak0 weeks
Active weeks in one year8
Trend breadth15.4%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.62Latest activity-pressure read.
Pressure change248.7%Four-week change in activity pressure.
Leadership-11.98Latest relative-leadership reading.
RS change2.2%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks strongly; valuation is inexpensive relative to peers.

Open full factor analysis
Factor week 09 Aug 2026 Financial statements through 31 Mar 2026 Field coverage 94% Model confidence 88%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength82/100Blend of value, momentum, and quality. Underlying universe rank 19; rank 1 is best.
Value87/100Relative valuation strength. Underlying universe rank 14; rank 1 is best.
Quality64/100Profitability and accounting quality. Underlying universe rank 37; rank 1 is best.
Momentum26/100Medium-term price momentum. Underlying universe rank 75; rank 1 is best.
Growth81/100Revenue and earnings growth. Underlying universe rank 20; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework70/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
9.6x
Price divided by trailing earnings.
Price / sales
0.6x
Market value relative to trailing revenue.
EV / EBITDA
5.4x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
6.9%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
34.0%
Gross profit retained from each unit of revenue.
Operating margin
5.2%
Operating profit retained from revenue.
Free-cash-flow margin
4.6%
Free cash flow generated from revenue.
Return on invested capital
10.3%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
1.2%
Latest one-year revenue growth.
EPS growth
202.1%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
11.1%
Latest one-year free-cash-flow growth.
Piotroski F-score
7/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
6.0%
Cash dividends relative to market value.
Buyback yield
0.1%
Net share repurchases relative to market value.
Shareholder yield
6.1%
Dividend yield plus net buyback yield.
Net debt / EBITDA
-0.3x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment50/100

Weighted news tone is neutral across 4 relevant articles.

0 positive · 4 neutral · 0 negative
Patient CapitalRecent

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

Recent buy signal in the last 8 weeks
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-30.8%Distance below the 52-week high.
13-week volatility4.5%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher15 of 2611 weeks finished lower.
Best week+12.2%Week of 20 Feb.
Worst week-18.8%Week of 13 Feb.
Latest week+0.9%Week of 7 Aug.

Shape of recent returns

Strong gains6
Modest gains9
Flat weeks0
Modest losses3
Sharp losses8
Recent vol4.5%13-week weekly-return volatility.
Base vol6.4%52-week weekly-return volatility.
Up/down split27/24Count of positive and negative weeks in the 52-week window.
Average skew4.7% / -5.2%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape33/100

Trend, activity pressure, participation, and risk combine to a 33/100 tape read.

 Indicator analysis17/100

Latest 12-week confirmation: trend 0/12, activity pressure 3/12, relative leadership 0/12.

Activity pressure 0.16; No reversal markers Factors65/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 40; Small Cap Core rank 10 SVQF70/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 112.0 of 375 Patient CapitalRecent

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

Recent buy signal in the last 8 weeks Sentiment50/100

Weighted news tone is neutral across 4 relevant articles.

ALLGEIER SE: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution Insiders50/100

No recent insider transaction evidence is stored.

 Earnings50/100

No stored earnings event is currently attached to this ticker.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
7 Aug 202616.75 EUR0.9%16.95 EUR17.72 EUR0.62-11.9838.3KOff
31 Jul 202616.60 EUR5.7%17.13 EUR17.75 EUR0.41-10.7249.5KOff
24 Jul 202615.70 EUR-5.4%17.28 EUR17.79 EUR0.16-14.0732.7KOff
17 Jul 202616.60 EUR2.8%17.42 EUR17.83 EUR-0.01-8.6146.6KOff
10 Jul 202616.15 EUR2.2%17.54 EUR17.87 EUR-0.42-12.2619.9KOff
3 Jul 202615.80 EUR5.3%17.65 EUR17.91 EUR-0.74-16.844.3KOff
26 Jun 202615.00 EUR3.6%17.79 EUR17.96 EUR-0.96-17.8910.3KOff
19 Jun 202614.48 EUR-1.0%17.97 EUR18.02 EUR-1.00-22.046.2KOff
12 Jun 202614.62 EUR-4.0%18.04 EUR18.08 EUR-0.85-20.6322.0KOff
5 Jun 202615.23 EUR-5.8%18.13 EUR18.15 EUR-0.92-18.216.3KOff
29 May 202616.17 EUR2.1%18.18 EUR18.21 EUR-1.03-14.7752.1KOff
22 May 202615.84 EUR10.5%18.26 EUR18.27 EUR-1.14-15.92104.4KOff
15 May 202614.34 EUR0.3%18.33 EUR18.32 EUR-1.26-21.07128.9KOff
8 May 202614.30 EUR-5.9%18.39 EUR18.38 EUR-1.07-22.9150.0KOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.

Evidence context